Literature DB >> 18567083

Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines.

Vijayakumar Velu1, Shanmugam Saravanan, Subhadra Nandakumar, Esaki-Muthu Shankar, Appasamy Vengatesan, Suresh-Sakharam Jadhav, Prasad-Suryakant Kulkarni, Sadras-Panchatcharam Thyagarajan.   

Abstract

AIM: To investigate the cellular defects by analyzing the (Th1/Th2) cytokine levels in vaccine responders and non-responders.
METHODS: Peripheral blood mononuclear cell (PBMC) from responders and non-responders were stimulated with or with out recombinant HBsAg or PHA. Broad spectrum of cytokines viz (Th1) IFN-gamma, IL-2, TNF-alpha, IL-12 and (Th2) IL-10, IL-4 were measured after in vitro stimulation with recombinant HBsAg and were compared with respective antibody titers.
RESULTS: A significant decrease (P = 0.001) in Th1 and Th2 cytokines namely, IL-2, INF-gamma, TNF-alpha and IL-10 in non-responders was observed. The level of IL-4 was not significant between the three groups. Furthermore, despite a strong Th1 and Th2 cytokine response, the level of IL-12 was elevated in high-responders compared to other groups (P = 0.001) and demonstrated a positive correlation with anti-HBs titers and Th1 cytokine response.
CONCLUSION: Our findings suggest that unresponsiveness to recombinant hepatitis B vaccines (rHB) is multifactorial, including specific failure of antigen presentation or the lack of both T helper Th1 and Th2 response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567083      PMCID: PMC2716617          DOI: 10.3748/wjg.14.3534

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

Authors:  A Bertoletti; M K Maini
Journal:  Curr Opin Microbiol       Date:  2000-08       Impact factor: 7.934

2.  Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen.

Authors:  C E Larsen; J Xu; S Lee; D P Dubey; G Uko; E J Yunis; C A Alper
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

3.  Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.

Authors:  W O Böcher; S Herzog-Hauff; J Schlaak; K H Meyer zum Büschenfeld; H F Löhr
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

Review 4.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

Review 5.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

6.  Defect in Th1-like cells of nonresponders to hepatitis B vaccine.

Authors:  M G Chedid; H Deulofeut; D E Yunis; M L Lara-Marquez; M Salazar; R Deulofeut; Z Awdeh; C A Alper; E J Yunis
Journal:  Hum Immunol       Date:  1997-11       Impact factor: 2.850

7.  Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine.

Authors:  M C Honorati; P Dolzani; E Mariani; A Piacentini; G Lisignoli; C Ferrari; A Facchini
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

8.  Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.

Authors:  B D Livingston; J Alexander; C Crimi; C Oseroff; E Celis; K Daly; L G Guidotti; F V Chisari; J Fikes; R W Chesnut; A Sette
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

9.  Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production.

Authors:  J Vingerhoets; G Vanham; L Kestens; G Penne; G Leroux-Roels; P Gigase
Journal:  Immunol Lett       Date:  1994-02       Impact factor: 3.685

Review 10.  Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond.

Authors:  H S Margolis
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  13 in total

1.  Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Authors:  Benjamin J Umlauf; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

2.  Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects.

Authors:  Irene Cassaniti; Sandra A Calarota; Kodjo M G Adzasehoun; Antonella Chiesa; Giuditta Comolli; Maurizio Parea; Fausto Baldanti
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

3.  Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine.

Authors:  Maria Bolther; Karen Lise Dahl Andersen; Martin Tolstrup; Kumar Visvanathan; Ian Woolley; Narelle Skinner; Rosemary Millen; Nadia Warner; Lars Østergaard; Søren Jensen-Fangel
Journal:  Hum Vaccin Immunother       Date:  2018-04-11       Impact factor: 3.452

4.  Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.

Authors:  Rebecca Erwin-Cohen; Aimee Porter; Phillip Pittman; Cynthia Rossi; Luis Dasilva
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

5.  Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.

Authors:  Akihiro Tamori; Tatsuya Koike; Hitoshi Goto; Shigeyuki Wakitani; Masahiro Tada; Hiroyasu Morikawa; Masaru Enomoto; Masaaki Inaba; Tatsuya Nakatani; Masayuki Hino; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2011-01-19       Impact factor: 7.527

6.  Establishment of an enzyme-linked immunosorbent assay system for determining soluble CD96 and its application in the measurement of sCD96 in patients with viral hepatitis B and hepatic cirrhosis.

Authors:  J Gong; C Zhu; R Zhuang; C Song; Q Li; Z Xu; Y Wei; K Yang; A Yang; L Chen; B Jin
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

7.  Risk factors of hepatitis B transmission in northern Palestine: a case - control study.

Authors:  Zaher Nazzal; Inam Sobuh
Journal:  BMC Res Notes       Date:  2014-03-28

8.  Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

Authors:  Andreia Ribeiro; Paula Laranjeira; Sandrine Mendes; Isabel Velada; Cristiana Leite; Pedro Andrade; Francisco Santos; Ana Henriques; Mário Grãos; Carla M P Cardoso; António Martinho; Mluísa Pais; Cláudia Lobato da Silva; Joaquim Cabral; Hélder Trindade; Artur Paiva
Journal:  Stem Cell Res Ther       Date:  2013-10-15       Impact factor: 6.832

9.  Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.

Authors:  Diana K Riner; Eric M Ndombi; Jennifer M Carter; Amos Omondi; Nupur Kittur; Emmy Kavere; Harrison K Korir; Briana Flaherty; Diana Karanja; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2016-12-07

10.  Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study.

Authors:  Simin Wen; Yanhua Wu; Yuchen Pan; Mengzhuo Cao; Dan Zhao; Chong Wang; Chuan Wang; Fei Kong; Jie Li; Junqi Niu; Jing Jiang
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.